Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

1. Previously bilaterally implanted with TECNIS Odyssey IOL, following cataract extraction;

2. Enrollment at least 21 days after second eye surgery;

3. Clear intraocular media in each eye.

4. Signed consent and data protection documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.

1. Concurrent participation in an interventional clinical trial during the time from which the data will be collected;

2. Use of systemic or ocular medication that may affect vision;

3. Prior corneal refractive surgery in each eye (i.e., LASIK, PRK, SMILE, RK, CK); NOTE: Limbal relaxing incisions (LRI) are permissible as planned at the time of surgery (intraoperatively) but not postoperatively within the retrospective analysis window;

4. Ongoing adverse events in each eye that might impact outcomes during the study visit as determined by the investigator;

5. Acute or chronic disease or condition, ocular trauma or surgery that may affect vision in each eye (e.g., clinically significant macular degeneration, glaucoma, cystoid macular edema, proliferative diabetic retinopathy, keratoconus etc.).

6. Amblyopia, strabismus, nystagmus in each eye.